metformin has been researched along with u 0126 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Chabrolle, C; Dupont, J; Tosca, L; Uzbekova, S | 1 |
Arlot-Bonnemains, Y; Dalbiès-Tran, R; Dupont, J; Mermillod, P; Papillier, P; Pennetier, S; Perreau, C; Prigent, C; Thélie, A; Uzbekov, R; Uzbekova, S | 1 |
Kawashima, I; Kirito, K; Mitsumori, T; Nakajima, K; Nozaki, Y; Shobu-Sueki, Y; Yamamoto, T | 1 |
Fu, CN; Gao, WS; Qu, YJ; Song, SS; Wei, H; Yue, SW | 1 |
4 other study(ies) available for metformin and u 0126
Article | Year |
---|---|
Possible role of 5'AMP-activated protein kinase in the metformin-mediated arrest of bovine oocytes at the germinal vesicle stage during in vitro maturation.
Topics: AMP-Activated Protein Kinases; Animals; Blotting, Western; Butadienes; Cattle; Cell Cycle; Enzyme Activation; Enzyme Inhibitors; Female; Immunohistochemistry; In Vitro Techniques; Metformin; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Multienzyme Complexes; Nitriles; Oocytes; Phosphorylation; Progesterone; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines | 2007 |
Spatio-temporal expression patterns of aurora kinases a, B, and C and cytoplasmic polyadenylation-element-binding protein in bovine oocytes during meiotic maturation.
Topics: Animals; Aurora Kinase A; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Butadienes; Cattle; CDC2 Protein Kinase; Cyclin B; Cyclin B1; Cytoplasm; Embryo, Mammalian; Female; Fertilization; Meiosis; Metformin; mRNA Cleavage and Polyadenylation Factors; Nitriles; Oocytes; Piperazines; Polyadenylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-mos; Purines; RNA, Messenger; Roscovitine | 2008 |
Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Topics: Adult; Aged; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Butadienes; Cell Line, Tumor; Drug Interactions; Dual Specificity Phosphatase 6; Enzyme Activation; Feedback, Physiological; Female; Glucose; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; MAP Kinase Signaling System; Metformin; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Proteins; Nitriles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured | 2015 |
Obesity increases neuropathic pain via the AMPK-ERK-NOX4 pathway in rats.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Butadienes; Diet, High-Fat; Disease Models, Animal; Enzyme Inhibitors; Ganglia, Spinal; Hypoglycemic Agents; Inflammation; Male; MAP Kinase Signaling System; Metformin; NADPH Oxidase 4; Neuralgia; Nitriles; Obesity; Oxidative Stress; Pain Threshold; Phosphorylation; Rats, Wistar; Ribonucleotides; Spinal Cord | 2021 |